Sichuan Kelun Pharmaceutical Hits Day High with 8.75% Surge

Sichuan Kelun Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 8.75% on March 27, 2026. The stock reached an intraday high of CNY 35.11, reflecting a strong day of trading for the large-cap company in the Pharmaceuticals & Biotechnology sector. In terms of performance metrics, Sichuan Kelun has shown resilience over various time frames. Over the past month, the stock has appreciated by 14.34%, while its year-to-date performance stands at 18.98%. Comparatively, the China Shanghai Composite index has struggled, with a year-to-date decline of 1.39%. Despite the positive daily performance, the company has faced challenges, including a notable decline in net sales of 15.48% reported in September. Additionally, the operating cash flow has reached its lowest point at CNY 3,073.46 million, and the return on capital employed (ROCE) is currently at 7.2%. Overall, Sichuan Kelun Pharmaceutical Co., Ltd. continues to navigate a complex market landscape while achieving notable daily gains.